Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It was originally developed and approved by the FDA for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution, particularly excess fat buildup in the abdominal area. As a synthetic analog of GHRH, tesamorelin stimulates the pituitary gland to release more endogenous growth hormone (GH), which in turn increases insulin-like growth factor 1 (IGF-1) levels in the body. This hormonal boost has profound effects on metabolism, fat distribution, and even cognitive function.
Tag Archives: Tesamorelin
Peptide for Metabolic Health and Fat Reduction
A Targeted Peptide for Metabolic and Hormonal Health